SGLT2i Dapagliflozin in primary prevention of chemotherapy induced cardiotoxicity in breast cancer patients treated with neo-adjuvant anthracycline-based chemotherapy +/- trastuzumab: rationale and design of the multicenter PROTECT trial

Alessandra Greco, Laura Scelsi, Gianpiero Rizzo et al.|Cardio-Oncology|2025

Cited by 5